Rectal swab test to predict resistant infections in ICU
Part of Infections clinical trials.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You were in a medical or surgical intensive care unit at Strasbourg University Hospitals between January 1, 2024, and January 1, 2025.
- You had a rectal swab to check for certain resistant bacteria (ESBL, HLC, or carbapenemase-producing Enterobacteriaceae).
- You have not refused to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain bacteria that carry ESBL enzymes are spreading between people. To join, you would need lab-confirmed evidence that you carry these bacteria based on routine samples taken during usual care.
This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
This study looks at whether patients in the intensive care unit (ICU) carry certain hard-to-treat bacteria (carbapenem-resistant enterobacteriaceae, or CRE) in their gut. By finding out how common this is, doctors can better protect patients from infections.
This study looks at how certain bacteria (Klebsiella pneumoniae and Enterobacter cloacae) change over time in the stool of ICU patients staying at least 28 days. It aims to understand why these infections occur and how they evolve, which could help improve future care.
This study looks at a faster test to find CPE, a type of bacteria that is resistant to many antibiotics. If you test positive for CPE while in the hospital, your information may be used to help improve how we screen and manage this bacteria.
Hear when a new Infections, Enterobacteriaceae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.